Amundi NASDAQ-100 UCITS ETF - USD (C)
| Issuer: Amundi ETF |
| Asset Class: Equity |
| TER: 23bps |
| Trading Currency: GBX |
| Pays Income: False |
| Listing Date: 18 Apr 2018 |
| Ticker: ANXG |
| ISIN: LU1681038326 |
This fund offers targeted exposure to the 100 largest non-financial companies listed on a major U.S. stock exchange, providing a concentrated portfolio of market-leading and innovative firms. The investment vehicle is designed to closely track the performance of an index heavily weighted towards the technology sector, but also includes significant allocations to consumer discretionary, communication services, and healthcare. It serves as a strategic tool for investors seeking to capture the growth potential of influential, forward-looking businesses that are shaping the future of the global economy. By investing in this basket of companies, one gains access to pioneers in areas such as artificial intelligence, cloud computing, e-commerce, and biotechnology.
The underlying portfolio consists of companies known for their strong growth profiles and dominant market positions. This focus on high-growth potential naturally comes with a higher level of volatility compared to broader, more diversified market indices. Therefore, this product is particularly suitable for investors with a long-term investment horizon and a higher tolerance for risk, who are optimistic about the continued leadership and innovation within the U.S. large-cap growth segment. As an accumulating share class, any dividends paid by the constituent companies are automatically reinvested back into the fund, which facilitates the power of compounding returns over time.
The fund employs a synthetic replication methodology, utilizing a swap agreement to deliver the index's return. This approach can lead to very precise tracking of the benchmark and may offer cost efficiencies compared to physically holding all the underlying securities. For investors looking for an efficient and cost-effective way to gain focused exposure to America's most prominent technology and growth companies, this instrument represents a compelling and accessible option.
